Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Nanomedicine Market from 2024 to 2025?

The expansion of the nanomedicine market has been swift in the past few years. The market is projected to escalate from $331.61 billion in 2024 to $379.24 billion in 2025, with a compound annual growth rate (CAGR) of 14.4%. The growth during the historical period is linked to improved knowledge of molecular biology, a rise in chronic disease incidence, the need for precision drug delivery mechanisms, the development of nanoparticle imaging technologies, and a growing elderly population.

What Is the Projected Market Size of the Nanomedicine Market?

In the coming years, a significant expansion is anticipated in the nanomedicine market, with predictions estimating its worth to reach $690.96 billion by 2029, marking a CAGR of 16.2%. The growth expected in this period is linked to the consistent advances in nanotechnology studies, heightened support in nanomedicine research and development, an intensified push for individualized medicine, extensive applications in nanomedicine-based cancer therapy, and the utilization of nanomedicine for infectious disease treatments. Key trends for the forecast period include the production of multi-functional nanoparticles for therapeutics and imaging, the focus on nanoparticle-aided diagnostics and imaging agents, the use of nanomedicine in the sphere of regenerative medicine, the rising employment of nanomedicine in targeted treatment for neurological conditions, and cooperations and alliances in nanomedicine research and commercialization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5344&type=smp

Who are the Major Competitors in the Nanomedicine Market Outlook?

Major companies operating in the nanomedicine market include Pfizer Inc., Ablynx NV, Amgen Inc., Arrowhead Research Inc., Bio-Gate AG, Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc., Camurus AB, Cerulean Pharma Inc., CytImmune Sciences, Fujifilm Holdings, Nanobiosym Inc., Nanobiotix SA, Nanogen Inc., Nanoparticle BioChem Inc., Nanospective Inc., Nanosphere Health Sciences Inc., Nanosys Inc., PerkinElmer Inc., Selecta Biosciences Inc.

What Is Fueling Growth in the Nanomedicine Market?

The global surge in complex and chronic diseases is anticipated to spur the expansion of the nanomedicine market in the upcoming years. The use of nanomedicine in addressing chronic diseases such as cardiovascular diseases, diabetes, cancer, dementia, among others has seen significant growth due to its ability to hasten drug metabolism inside the body. For example, the International Federation of Alzheimer’s Associations, Alzheimer’s Disease International highlights that there are over 50 million active cases of dementia worldwide, with projections indicating that this number may double every two decades, reaching 80 million by 2030 and 152 million by 2050. The overall global incidence of cancer is also predicted to increase, resulting in 28.4 million new cancer cases by 2040. This rising prevalence of chronic diseases creates a higher demand for effective therapeutic treatments employing nanomedicine, contributing to the expansion of the nanomedicine market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5344&type=smp

Which Nanomedicine Market Segments Are Growing the Fastest?

The nanomedicine market covered in this report is segmented –

1) By Type: Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types

2) By Modality: Diagnostics, Treatments

3) By Application: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications

Subsegments:

1) By Nanoparticles: Lipid-Based Nanoparticles, Polymeric Nanoparticles, Metallic Nanoparticles, Ceramic Nanoparticles

2) By Nanoshells: Gold Nanoshells, Silver Nanoshells, Silica Nanoshells

3) By Nanotubes: Carbon Nanotubes (CNTs), Polymer Nanotubes

4) By Nanodevices: Nanosensors, Nanorobots, Nanoscale Imaging Devices

5) By Other Types: Dendrimers, Quantum Dots, Nanocarriers

Which Industry Trends Are Shaping the Future of the Nanomedicine Market?

Top firms in the nanomedicine market such as Waters Corporation are leveraging innovative products like dynapro zetastar to boost their market revenues. This groundbreaking device allows for concurrent measurements of dynamic, static, and electrophoretic light scattering (DLS/SLS/ELS). In September 2023, Waters Corporation, a US company specializing in analytical laboratory equipment and instruments, introduced the dynapro zetastar for nanoparticle assessment. The instrument facilitates the precise development of intricate biologics by integrating different light scattering techniques, executing adaptive data collection, automatically evaluating data quality, and enhancing the sensitivity and speed of measurements using minimal sample volumes. The exceptional flow cell design of the zetastar allows it to connect to an autosampler, thus significantly enhancing lab productivity and efficiency by facilitating multiple unattended measurements over extended periods, including several hours or even overnight.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Which Countries Are Leading the Nanomedicine Market?

North America was the largest region in the nanomedicine market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5344

This Report Delivers Insight On:

1. How big is the nanomedicine market, and how is it changing globally?

2. Who are the major companies in the nanomedicine market, and how are they performing?

3. What are the key opportunities and risks in the nanomedicine market right now?

4. Which products or customer segments are growing the most in the nanomedicine market?

5. What factors are helping or slowing down the growth of the nanomedicine market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model